About Walvax
Walvax is a company based in Kunming (China) founded in 2001.. The company has 1,930 employees as of December 31, 2024. Walvax operates in a competitive market with competitors including Serum Institute of India, Vaxcyte, HOOKIPA Pharma, Vir Biotechnology and Biological E, among others.
- Headquarter Kunming, China
- Employees 1930 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Walvax Biotechnology Co., Ltd. Class A
-
Annual Revenue
$383.59 M (USD)-31.34as on Dec 31, 2024
-
Net Profit
$19.48 M (USD)-66.1as on Dec 31, 2024
-
EBITDA
$66.9 M (USD)-50.53as on Dec 31, 2024
-
Latest Funding Round
$72.8 M (USD), Post-IPO
Aug 10, 2014
-
Investors
-
Employee Count
1930
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Walvax
Walvax is a publicly listed company on the SZSE with ticker symbol 300142 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Walvax
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $72.8M
-
First Round
First Round
(10 Aug 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2014 | Amount | Post-IPO - Walvax | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Walvax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Walvax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Walvax Comparisons
Competitors of Walvax
Walvax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Serum Institute of India, Vaxcyte, HOOKIPA Pharma, Vir Biotechnology and Biological E, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Walvax
Frequently Asked Questions about Walvax
When was Walvax founded?
Walvax was founded in 2001 and raised its 1st funding round 13 years after it was founded.
Where is Walvax located?
Walvax is headquartered in Kunming, China. It is registered at Kunming, Yunnan, China.
How many employees does Walvax have?
As of Dec 31, 2024, the latest employee count at Walvax is 1,930.
What is the annual revenue of Walvax?
Annual revenue of Walvax is $383.59M as on Dec 31, 2024.
What does Walvax do?
Walvax was founded in 2001 in Kunming, China, as a vaccine manufacturer focused on the biopharmaceutical sector. Specialization is placed on developing and producing vaccines against meningitis and influenza. An in-house RD center is operated to support innovation. The company was listed publicly in November 2010, enabling expanded operations within the Chinese market and beyond.
Who are the top competitors of Walvax?
Walvax's top competitors include Vaxcyte, HOOKIPA Pharma and Serum Institute of India.
Is Walvax publicly traded?
Yes, Walvax is publicly traded on SZSE under the ticker symbol 300142.
What is Walvax's ticker symbol?
The ticker symbol of Walvax is 300142 on SZSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.